ICE

SEC source: 0001209191-17-066358 · doc4.xml · derivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,620

Underlying: Common Stock · 2,000 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-066358 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,460 shares of common stock, 11,201 unvested restricted stock units, and 20,021 unvested performance based restricted stock units, for which the performance period has been satisfied. The restricted stock units and the performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-065940 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,682

F1 · shares: Represents shares of restricted stock issued to the filing person on December 13, 2017. This award of restricted stock vests over three years (1/3 on each anniversary of the award date).

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,460 shares of common stock, 11,201 unvested restricted stock units, and 20,021 unvested performance based restricted stock units, for which the performance period has been satisfied. The restricted stock units and the performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-065246 · doc4.xml · nonDerivative · entry 1

Bowen Sharon · CIK 0001724974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,467

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

SEC source: 0001209191-17-064728 · doc4.xml · nonDerivative · entry 1

Forneri Jean Marc · CIK 0001343872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,300

F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $70.33 - $70.96. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 16,350 shares of common stock and 2,950 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-063925 · doc4.xml · derivative · entry 3

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,955

Underlying: Common Stock · 7,500 shares

Expires 2023-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-063925 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $71.495 - $72.210. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-063925 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-059421 · doc4.xml · derivative · entry 4

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,455

Underlying: Common Stock · 12,500 shares

Expires 2023-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-059421 · doc4.xml · nonDerivative · entry 3

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $68.48 - $69.13. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-059421 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,271

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $67.47 - $68.47. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-059421 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-056633 · doc4.xml · nonDerivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,050

F1 · shares: Represents shares of common stock underlying vested restricted stock that are being withheld to satisfy payment of the Issuer's tax withholding obligation upon the vesting of the restricted stock units. The shares of restricted stock units were granted to the filing person on October 9, 2014. One-third of the restricted stock units vested each year over a three year period from 2015-2017. The third and final tranche of shares for this award has vested.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 99,996 shares of common stock and 50,054 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-056488 · doc4.xml · derivative · entry 7

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,955

Underlying: Common Stock · 3,845 shares

Expires 2023-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-056488 · doc4.xml · derivative · entry 6

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,655 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-056488 · doc4.xml · nonDerivative · entry 5

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-056488 · doc4.xml · nonDerivative · entry 4

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,071

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $70.04 - $71.04. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-056488 · doc4.xml · nonDerivative · entry 3

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,371

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $69.00 - $69.96. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-056488 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-056488 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 378,626

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-056161 · doc4.xml · derivative · entry 4

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,730 shares

Expires 2018-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-056161 · doc4.xml · nonDerivative · entry 3

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,845

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $70.00 - $70.16. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 134,776 shares of common stock and 60,069 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-056161 · doc4.xml · nonDerivative · entry 2

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,623

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-056161 · doc4.xml · nonDerivative · entry 1

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,893

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-052174 · doc4.xml · derivative · entry 4

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,655

Underlying: Common Stock · 12,500 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-052174 · doc4.xml · nonDerivative · entry 3

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $65.10 - $65.60. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-052174 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,671

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $63.97 - $64.92. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-052174 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-050293 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 113,554

F1 · shares: The sales reported in this Form 4 were effected pursuant to a previously announced, pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F5 · price: The price range for the aggregate amount sold by the direct holder is $65.00 - $65.60. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 98,535 shares of common stock and 15,019 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

F7 · balance_after: As previously reported, the reporting person also indirectly owns 3,791,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person also beneficially owns shares directly.

SEC source: 0001209191-17-050293 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,501,273

F1 · shares: The sales reported in this Form 4 were effected pursuant to a previously announced, pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $65.00 - $65.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,361,105 shares of common stock and 140,168 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

F4 · balance_after: As previously reported, the reporting person also indirectly owns 3,791,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

SEC source: 0001209191-17-047719 · doc4.xml · derivative · entry 3

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,155

Underlying: Common Stock · 12,500 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-047719 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $66.760 - $67.270. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-047719 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-044373 · doc4.xml · derivative · entry 3

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,655

Underlying: Common Stock · 15,000 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-044373 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $65.895 - $66.670. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-044373 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-042277 · doc4.xml · nonDerivative · entry 1

Hill Scott A · CIK 0001397778 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,745

F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 152,676 shares of common stock and 60,069 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-038874 · doc4.xml · nonDerivative · entry 2

Forneri Jean Marc · CIK 0001343872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,300

F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 24,350 shares of common stock and 2,950 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-038874 · doc4.xml · nonDerivative · entry 1

Forneri Jean Marc · CIK 0001343872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,300

F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-038293 · doc4.xml · nonDerivative · entry 1

Forneri Jean Marc · CIK 0001343872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,300

F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $61.62 - $61.93. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 28,350 shares of common stock and 2,950 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-038125 · doc4.xml · derivative · entry 3

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,655

Underlying: Common Stock · 15,000 shares

Expires 2022-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-17-038125 · doc4.xml · nonDerivative · entry 2

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,971

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $60.24 - $60.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 279,861 shares of common stock and 90,110 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

SEC source: 0001209191-17-038125 · doc4.xml · nonDerivative · entry 1

Vice Charles A · CIK 0001343884 · President&Chief Op. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-17-037247 · doc4.xml · nonDerivative · entry 1

TESE VINCENT · CIK 0001042445 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,626

F1 · shares: This transaction involved a gift of 2,800 shares of the issuer's common stock by the reporting person to philanthropic organizations.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 28,255 shares of common stock and 3,371 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-035744 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,001

F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $59.73 - $60.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,630 shares of common stock and 3,371 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-035743 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 121,358

F1 · shares: The sales reported in this Form 4 were effected pursuant to a previously announced, pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F5 · price: The price range for the aggregate amount sold by the direct holder is $59.66 - $60.10. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 106,339 shares of common stock and 15,019 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

F7 · balance_after: As previously reported, the reporting person also indirectly owns 3,791,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person also beneficially owns shares directly.

SEC source: 0001209191-17-035743 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,573,889

F1 · shares: The sales reported in this Form 4 were effected pursuant to a previously announced, pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $59.64 - $60.12. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,433,721 shares of common stock and 140,168 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2018 and will be reported at the time of vesting. The satisfaction of the 2017 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting.

F4 · balance_after: As previously reported, the reporting person also indirectly owns 3,791,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

SEC source: 0001209191-17-034637 · doc4.xml · nonDerivative · entry 1

CRISP CHARLES R · CIK 0001015825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,825

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 50,875 shares of common stock and 2,950 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-034655 · doc4.xml · nonDerivative · entry 1

NOONAN THOMAS E · CIK 0001079742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,065

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: On November 3, 2016, the common stock of Intercontinental Exchange, Inc. split 5-for-1 (the "Stock Split"), resulting in the reporting person's ownership of four additional shares of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 3,115 shares of restricted stock units of the Issuer that vest on the one-year anniversary of the grant date, which is September 22, 2017 and 2,950 restricted stock units of the Issuer that vest on the one-year anniversary of the grant date, which is May 19, 2018.

SEC source: 0001209191-17-034664 · doc4.xml · nonDerivative · entry 1

TESE VINCENT · CIK 0001042445 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,426

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 3,371 restricted stock units awarded, 2,950 were awarded as compensation for service on the Issuer's board and 421 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

F2 · balance_after: On November 3, 2016, the common stock of Intercontinental Exchange, Inc. split 5-for-1 (the "Stock Split"), resulting in the reporting person's ownership of four additional shares of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,050 shares of common stock and 3,371 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2018.